Technical Analysis for ACXP - Acurx Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 5.06 -1.36% -0.07
ACXP closed down 1.36 percent on Wednesday, August 4, 2021, on 17 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical ACXP trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup -1.36%
20 DMA Resistance Bearish -8.33%
Outside Day Range Expansion -8.33%
Older End-of-Day Signals for ACXP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 20 hours ago
Lower Bollinger Band Support about 20 hours ago
Down 1% about 21 hours ago
Up 2% about 21 hours ago
Up 1% about 21 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.
Classification

Keywords: Health Care Bacterial Infections Antibiotics Healthcare Associated Infections Staphylococcus Aureus Methicillin Vancomycin

Is ACXP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.74
52 Week Low 5.0003
Average Volume 652,545
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 5.64
10-Day Moving Average 5.39
Average True Range 0.52
ADX 22.82
+DI 11.60
-DI 20.19
Chandelier Exit (Long, 3 ATRs) 4.78
Chandelier Exit (Short, 3 ATRs) 6.57
Upper Bollinger Bands 6.29
Lower Bollinger Band 4.98
Percent B (%b) 0.06
BandWidth 23.28
MACD Line -0.30
MACD Signal Line -0.26
MACD Histogram -0.0466
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.45
Resistance 3 (R3) 5.47 5.37 5.38
Resistance 2 (R2) 5.37 5.27 5.35 5.36
Resistance 1 (R1) 5.21 5.21 5.16 5.19 5.34
Pivot Point 5.11 5.11 5.08 5.10 5.11
Support 1 (S1) 4.95 5.01 4.90 4.93 4.78
Support 2 (S2) 4.85 4.95 4.84 4.76
Support 3 (S3) 4.69 4.85 4.74
Support 4 (S4) 4.67